192 related articles for article (PubMed ID: 9685344)
1. Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription.
Sawaya BE; Khalili K; Mercer WE; Denisova L; Amini S
J Biol Chem; 1998 Aug; 273(32):20052-7. PubMed ID: 9685344
[TBL] [Abstract][Full Text] [Related]
2. Interplay between HIV-1 Vpr and Sp1 modulates p21(WAF1) gene expression in human astrocytes.
Amini S; Saunders M; Kelley K; Khalili K; Sawaya BE
J Biol Chem; 2004 Oct; 279(44):46046-56. PubMed ID: 15302882
[TBL] [Abstract][Full Text] [Related]
3. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat.
Wang L; Mukherjee S; Jia F; Narayan O; Zhao LJ
J Biol Chem; 1995 Oct; 270(43):25564-9. PubMed ID: 7592727
[TBL] [Abstract][Full Text] [Related]
4. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
Sawaya BE; Khalili K; Amini S
J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
[TBL] [Abstract][Full Text] [Related]
5. Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome.
Sawaya BE; Khalili K; Gordon J; Taube R; Amini S
J Biol Chem; 2000 Nov; 275(45):35209-14. PubMed ID: 10931842
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
7. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
Subler MA; Martin DW; Deb S
J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
9. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1.
Majello B; De Luca P; Hagen G; Suske G; Lania L
Nucleic Acids Res; 1994 Nov; 22(23):4914-21. PubMed ID: 7800480
[TBL] [Abstract][Full Text] [Related]
10. p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat.
Gualberto A; Baldwin AS
J Biol Chem; 1995 Aug; 270(34):19680-3. PubMed ID: 7649977
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines.
Gummuluru S; Emerman M
J Virol; 1999 Jul; 73(7):5422-30. PubMed ID: 10364289
[TBL] [Abstract][Full Text] [Related]
12. Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx.
Philippon V; Matsuda Z; Essex M
J Hum Virol; 1999; 2(3):167-74. PubMed ID: 10413368
[TBL] [Abstract][Full Text] [Related]
13. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
[TBL] [Abstract][Full Text] [Related]
14. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
Kamine J; Subramanian T; Chinnadurai G
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
16. p53 represses Sp1 DNA binding and HIV-LTR directed transcription.
Bargonetti J; Chicas A; White D; Prives C
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):935-49. PubMed ID: 9449526
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro.
Vanitharani R; Mahalingam S; Rafaeli Y; Singh SP; Srinivasan A; Weiner DB; Ayyavoo V
Virology; 2001 Oct; 289(2):334-42. PubMed ID: 11689055
[TBL] [Abstract][Full Text] [Related]
18. High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia.
Burdo TH; Nonnemacher M; Irish BP; Choi CH; Krebs FC; Gartner S; Wigdahl B
DNA Cell Biol; 2004 Apr; 23(4):261-9. PubMed ID: 15142383
[TBL] [Abstract][Full Text] [Related]
19. Suppression of HIV-1 transcription and replication by a Vpr mutant.
Sawaya BE; Khalili K; Rappaport J; Serio D; Chen W; Srinivasan A; Amini S
Gene Ther; 1999 May; 6(5):947-50. PubMed ID: 10505122
[TBL] [Abstract][Full Text] [Related]
20. Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains.
Berkhout B; Verhoef K; van Wamel JL; Back NK
J Virol; 1999 Feb; 73(2):1138-45. PubMed ID: 9882315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
